Free equity investment tool of Japanese companies

Credit Rating Analysis

Annual

First quarter

Second quarter

Third quarter

Sponsored Link

Related Company

あすか製薬

TOSOH

MITSUBISHI PLASTICS

ZERIA PHARMACEUTICAL

Lion

TAIKO PHARMACEUTICAL

Shikoku Chemicals

ステラケミファ

TERAOKA SEISAKUSHO

SANKO GOSEI

SEIKAGAKU　

Sumitomo Seika Chemicals

HAGIHARA INDUSTRIES

NIPPON CHEMIPHAR

Ube Industries

EDIUNET Related Ranking

EDIUNET

EDIUNET Credit Rating

EDIUNET Industry Avg

EDIUNET Prefectures

Yuho! Industry

EDIUNET Rating News

Prev « 2024-04 » Next

Mon	Tue	Wed	Thu	Fri	Sat	Sun
1 -	2 -	3 -	4 -	5 -	6 -	7 -
8 -	9 -	10 -	11 -	12 -	13 -	14 -
15 -	16 -	17 -	18 -	19 -	20 -	21 -
22 -	23 -	24 -	25 -	26 -	27 -	28 -
29 -	30 -

[Update list]

1/28 Retail Trade (CAWACHI:A etc...

1/27 Banks (The Awa Bank:BBB→A)

1/23 Chemicals (Milbon:AA→AAA)

1/21 Glass & Ceramics Products (..

1/21 Machinery (TSUDAKOMA:C)

1/21 Other Services (Netindex.:CC)

1/20 Other Products (Kurogane Kos..

1/20 Wholesale Trade (リーバイ・..

1/20 Other Services (川崎地質:BB→..

1/17 Chemicals (Kawaguchi Chemica..

 RSS

 Company RSS

 Daily RSS

Sponsored Link

Recently Download Chart

メルコホールディングス

Hitachi Zosen etc.

ROHM

NIPPON COKE & ENGINEERING

PIONEER

Credit Rating Analysis: Daito Pharmaceutical Co . (Annual )

The details of credit rating (bankruptcy risk) can be checked. A credit rating in nine stages (AAA-C).

【Analysis Menu】 Outline Statement Rating Indicator Download

Sponsored Link

Credit Rating (Bankruptcy Risk): Daito Pharmaceutical Co . (Annual ) Consolidated | Non-Consolidated

Date	Credit Rating	Comment	Sales	Current Profit	Net Income
2013-05-31	AA	Credit is very high, slightly affected by biz environs.	¥ 28 B 6.64%	¥ 2 B -1.20%	¥ 1 B 28.58%

Financial Timeline

Date	2013-02-28  (Third quarter )	2013-05-31  (Annual )	2013-08-31  (First quarter )	2013-11-30  (Second quarter )
Credit Rating	AA	AA	A	AA
Total Assets	¥ 34 B	¥ 34 B	¥ 35 B	¥ 36 B
Net Assets	¥ 14 B	¥ 15 B	¥ 15 B	¥ 15 B

Financial Statement Risk Analysis: Daito Pharmaceutical Co . (Annual ) (Consolidated )

Special note

Net sales and net income has increased 4 consecutive terms, and, because of positive operating cash flow. The performance is good.

Net Assets have increased 4consecutive terms. The fiscal base is getting better.

[Date: 2013-05-31]  Danger : Warning : Caution : Good

Dividend
Under the situation of Net Income (¥ 1 B) & Operating Cash Flow (¥ 2 B) , Dividend (¥ -268 M) is paid.

Financing Risk (*Operating Cash Flow is decrease )
Sales (¥ 28 B) is first term (¥ 27 B) more, however Operating Cash Flow (¥ 2 B) is first term (¥ 3 B) less , there is a possibility that the financing has deteriorated very much.

[Date: 2012-05-31]  Danger : Warning : Caution : Good

Financing Good (*Operating Cash Flow is plus )
Investment Cash Flow (¥ -3 B) & Financial Cash Flow (¥ -344 M) is a minus, Operating Cash Flow (¥ 3 B) is a plus,

Dividend
Under the situation of Net Income (¥ 1 B) & Operating Cash Flow (¥ 3 B) , Dividend (¥ -179 M) is paid.

[Date: 2011-05-31]  Danger : Warning : Caution : Good

Financing Good (*Operating Cash Flow is plus )
Investment Cash Flow (¥ -3 B) & Financial Cash Flow (¥ -349 M) is a minus, Operating Cash Flow (¥ 2 B) is a plus,

Dividend
Under the situation of Net Income (¥ 990 M) & Operating Cash Flow (¥ 2 B) , Dividend (¥ -179 M) is paid.

[Date: 2010-05-31]  Danger : Warning : Caution : Good

Dividend
Under the situation of Net Income (¥ 752 M) & Operating Cash Flow (¥ 2 B) , Dividend (¥ -107 M) is paid.

Credit Rating (Bankruptcy Risk): Daito Pharmaceutical Co . (Annual ) Consolidated | Non-Consolidated

Date	Credit Rating	Comment	Sales	Current Profit	Net Income
2013-05-31	AA	Credit is very high, slightly affected by biz environs.	¥ 28 B 6.82%	¥ 2 B -0.92%	¥ 1 B 31.50%

Financial Timeline

Date	-  (First quarter )	-  (Second quarter )	-  (Third quarter )	2013-05-31  (Annual )
Credit Rating	-	-	-	AA
Total Assets	-	-	-	¥ 31 B
Net Assets	-	-	-	¥ 13 B

Financial Statement Risk Analysis: Daito Pharmaceutical Co . (Annual ) (Non-Consolidated )

Special note

Net sales and net income has increased 4 consecutive terms. The performance is good.

Net Assets have increased 4consecutive terms. The fiscal base is getting better.

[Date: 2013-05-31]  Danger : Warning : Caution : Good

Dividend
Under the situation of Net Income (¥ 1 B) & Operating Cash Flow (-) , Dividend (¥ -268 M) is paid.

Non-performing asset Risk (*Accounts Receivable and Inventory, etc. confirmed content)
Other Current Assets first term ratio (¥ 2 B) is Sales first term ratio (¥ 1 B) more , there is a possibility that the non-performing asset was increased.

[Date: 2012-05-31]  Danger : Warning : Caution : Good

Dividend
Under the situation of Net Income (¥ 1 B) & Operating Cash Flow (-) , Dividend (¥ -179 M) is paid.

[Date: 2011-05-31]  Danger : Warning : Caution : Good

Dividend
Under the situation of Net Income (¥ 781 M) & Operating Cash Flow (-) , Dividend (¥ -179 M) is paid.

[Date: 2010-05-31]  Danger : Warning : Caution : Good

Dividend
Under the situation of Net Income (¥ 681 M) & Operating Cash Flow (-) , Dividend (¥ -107 M) is paid.

Related Information: Daito Pharmaceutical Co . (Annual )

Statement Type

Annual : Daito Pharmaceutical Co .

First quarter : Daito Pharmaceutical Co .

Second quarter : Daito Pharmaceutical Co .

Third quarter : Daito Pharmaceutical Co .

Analysis Menu

Outline : Daito Pharmaceutical Co .

Statement : Daito Pharmaceutical Co .

Rating : Daito Pharmaceutical Co .

Indicator : Daito Pharmaceutical Co .

Download : Daito Pharmaceutical Co .

Industry Comparison Ranking

Chemicals - EDIUNET Industry Rankings

Chemicals - EDIUNET Credit Rating

Chemicals - EDIUNET Industry Avg

Comparison with a neighboring company

Toyama - EDIUNET Prefectures

Toyama富山市 - EDIUNET Prefectures

Related company's newest statement

Date	Company	Credit Rating	Date
1/23	Milbon	AA→AAA	2013-12-20
1/17	Kawaguchi Chemical Indu..	BBB→BB	2013-11-30
1/17	SANKEI CHEMICAL	A	2013-11-30
1/15	HOKKO CHEMICAL INDUSTRY	BB→B	2013-11-30
1/15	Daito Pharmaceutical Co .	AA	2013-11-30 (Q2)
1/15	KAWAKAMI PAINT MFG.	B→BB	2013-11-30
1/15	旭化学工業	AA	2013-11-30 (Q1)
1/10	OSAKA ORGANIC CHEMICAL ..	BB→BBB	2013-11-30
1/10	HISAMITSU PHARMACEUTICAL	A	2013-11-30 (Q3)
1/10	AMS Life Science	BBB→BB	2013-11-30 (Q1)

EDIUNET Investment News (Chemicals)

1/23 Chemicals (Milbon:AA→AAA)

1/17 Chemicals (Kawaguchi Chemica..

1/15 Chemicals (HOKKO CHEMICAL IN..

1/10 Chemicals (OSAKA ORGANIC CHE..

1/9 Chemicals (SANKO GOSEI:A)

12/27 Chemicals (Niitaka:A)

12/18 Chemicals (KUMIAI CHEMICAL I..

12/12 Chemicals (IHARA CHEMICAL IN..

12/11 Chemicals (Konoshima Chemica..

12/10 Chemicals (NATOCO:AA)

Company Information

Ticker	Market	Industry	Month	report	Rating
Daito Pharmaceutical Co .	4577	TSE 1st	Chemicals	5	Annual	AA

Related Company

ステラケミファ (Sales ¥ 28 B)

SANYO CHEMICAL INDUSTRIES (Sales ¥ 142 B)

SEIKAGAKU　 (Sales ¥ 26 B)

Daito Pharmaceutical Co . (Sales ¥ 28 B)

MATSUMOTO YUSHI-SEIYAKU (Sales ¥ 27 B)

日本曹達 (Sales ¥ 127 B)

Ube Industries (Sales ¥ 626 B)

TERAOKA SEISAKUSHO (Sales ¥ 19 B)

扶桑化学工業 (Sales ¥ 27 B)

TAIKO PHARMACEUTICAL (Sales ¥ 7 B)

EBARA-UDYLITE　 (Sales ¥ 14 B)

MUTO SEIKO CO. (Sales ¥ 24 B)

Soken Chemical & Engineering (Sales ¥ 26 B)

関連する株式投資情報

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .